Good post. Posters need to understand, that even though the data has not been released to the market, it doesn’t mean Big Pharma haven’t seen it.
Biotechs often have in-depth disclosures with prospective partners/collaborators under a Non-Disclsure Agreement. Big Pharma are not waiting for an ASX announcement.
This is why these partnerships give us such a strong indication that HerVAX results are outstanding .
These discussions between IMU and Nig Pharma are invaluable for LC and the Board to get feedback and insights to what BP are looking for. Different companies have different agendas to pursue.
Ann: IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON, page-61
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |